Unraveling ambiguous NAT2 genotyping data

Clinical Chemistry

Volumn 54, Issue 8, 2008, Pages 1390-1394

  Agúndez, José A G ^a   Golka, Klaus ^b   Martínez, Carmen ^a   Selinski, Silvia ^c   Blaszkewicz, Meinolf ^b   García Martín, Elena ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^c TU DORTMUND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ARYLAMINE N ACETYLTRANSFERASE 2;

ACETYLATION; ALLELE; ARTICLE; GENE; GENE MAPPING; GENOTYPE; HAPLOTYPE; HUMAN; NAT2 GENE; PREDICTIVE VALIDITY; SINGLE NUCLEOTIDE POLYMORPHISM;

ARYLAMINE N-ACETYLTRANSFERASE; COMPUTATIONAL BIOLOGY; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 48949100515     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2008.105569     Document Type: Article

References (21)

1. Meyer UA, Zanger UM. Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu Rev Pharmacol Toxicol 1997;37:269-96.
2. Crook JE, Woosley RL, Leftwich RB, Natelson EA. Agranulocytosis during combined procainamide and phenytoin therapy. South Med J 1979;72:1599-601.
3. Colmenero JD, Fernandez-Gallardo LC, Agundez JA, Sedeno J, Benitez J, Valverde E. Possible implications of doxycycline-rifampin interaction for treatment of brucellosis. Antimicrob Agents Chemother 1994;38:2798-802.
4. Vineis P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly AK, et al. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev 2001;10:1249-52.
5. Golka K, Prior V, Blaszkewicz M, Bolt HM. The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences. Toxicol Lett 2002;128:229-41.
6. Agundez JA, Olivera M, Ladero JM, Rodriguez-Lescure A, Ledesma MC, Diaz-Rubio M, et al. Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers. Pharmacogenetics 1996;6:501-12.
7. Agundez JA, Martinez C, Olivera M, Ledesma MC, Ladero JM, Benitez J. Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population. Clin Pharmacol Ther 1994;56:202-9.
8. Zhu Y, Hein DW, Doll MA, Reynolds KK, Abudu N, Valdes R, Jr., et al. Simultaneous determination of 7 N-acetyltransferase-2 single-nucleotide variations by allele-specific primer extension assay. Clin Chem 2006;52:1033-9.
9. Brans R, Laizane D, Khan A, Blomeke B. N-acetyltransferase 2 genotyping: an accurate and feasible approach for simultaneous detection of the most common NAT2 alleles. Clin Chem 2004;50:1264-6.
10. Huang JX, Mehrens D, Wiese R, Lee S, Tam SW, Daniel S, et al. High-throughput genomic and proteomic analysis using microarray technology. Clin Chem 2001;47:1912-6.
11. Brodde OE, Leineweber K. Beta2-adrenoceptor gene polymorphisms. Pharmacogenet Genomics 2005;15:267-75.
12. Agundez JA, Olivera M, Martinez C, Ladero JM, Benitez J. Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population. Pharmacogenetics 1996;6:423-8.
13. Human NAT2 alleles (haplotypes). Available from: http://louisville.edu/ medschool/pharmacology/Human.NAT2.pdf.
14. Golka K, Blaszkewicz M, Samimi M, Bolt HM, Selinski S. Reconstruction of N-acetyltransferase 2 haplotypes using PHASE. Arch Toxicol 2008;82:265-70.
15. Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, Gibbs RA, et al. A second generation human haplotype map of over 3.1 million SNPs. Nature (Lond) 2007;449:851-61.
16. Martinez C, Agundez JA, Olivera M, Martin R, Ladero JM, Benitez J. Lung cancer and mutations at the polymorphic NAT2 gene locus. Pharmacogenetics 1995;5:207-14.
17. Garcia-Martin E, Martinez C, Pizarro RM, Garcia-Gamito FJ, Gullsten H, Raunio H, et al. CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity. Clin Pharmacol Ther 2002;71:196-204.
18. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-89.
19. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction. Am J Hum Genet 2003;73:1162-9.
20. Li N, Stephens M. Modeling linkage disequilibrium and identifying recombination hotspot using single-nucleotide polymorphism data. Genetics 2003;165:2213-33. Erratum: Genetics 2004;167:1039.
21. Sabbagh A, Darlu P. Inferring haplotypes at the NAT2 locus: the computational approach. BMC Genet 2005;6:30.